Another light pollution/health study using the massive UK #BioBank dataset. “Our findings provide evidence that a higher #ALAN exposure is associated with an increased risk of incident [ulcerative colitis], with a significant dose-response relationship, but not with [Crohn’s disease]. Further studies are needed to elucidate the impact of outdoor ALAN on disease pathogenesis and outcomes.”

https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1704450/abstract

#HumanHealth #LightPollution

Frontiers | Exposure To Outdoor Artificial Light At Night is associated with higher risk of Ulcerative Colitis: A Prospective Cohort Study Analysis Of 346,163 Participants In The UK Biobank

1.1 Background Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, and environmental factors are believed to ...

Frontiers

Civilisation is often defined by what it chooses not to let disappear. At #Uzhhorod National #University, scientists have built a #biobank that advances #genomics and type 1 #diabetes #research, even as #war continues. It already supports #international research and teaching, and aims to represent the #genetic #diversity of #Ukraine where there was once a blank space on the map. But biology is unforgiving. Without reliable #electricity, years of work and thousands of samples simply thaw into loss. A large backup battery can keep this knowledge alive.

So here is the plain question: would you like to support both Science AND Ukraine?

If yes, please chip in to my friends’ fundraiser. Some things are worth keeping powered on. https://gofund.me/92339d478

Africa: Rethinking Consent in Ancient DNA Research: [UCT] Would you choose to have a part of your body live on after you died? How might your choice affect your relatives - or even your entire community? http://newsfeed.facilit8.network/TPD5d2 #Africa #Consent #AncientDNA #EthicsInResearch #Biobank

⚠️ This implies that in survivors of mild COVID-19, which is most people, over 1 in 3 cases of new-onset dementia is due to COVID-19 ⚠️

adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection

compared with those in propensity-score-matched controls without COVID-19 and in individuals with non-COVID respiratory illnesses

COVID-19 survivors had a higher likelihood of developing new-onset dementia compared to uninfected controls

association between COVID-19 and all-cause dementia (adjusted Hazard Ratio: 1.58)

The underlying pathophysiology likely involves prothrombotic, inflammatory, and microvascular dysfunction mechanisms, contributing to cerebral small vessel disease, blood-brain barrier disruption, and chronic cerebral hypoperfusion, ultimately leading to cognitive impairments and dementia

https://www.nature.com/articles/s44400-025-00034-y

#SARSCoV2 #COVID #COVID19 #CovidIsNotOver #SARS2 #MaskUp #dementia #biobank #LongCOVID

COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years - npj Dementia

COVID-19 is associated with long-term neurological complications, but its impact on new-onset dementia (NOD), particularly vascular dementia (VaD) and Alzheimer’s disease (AD), remains unclear. We observed adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection. Incidences of various types of dementia (including all-cause dementia, AD, and VaD) in these individuals were compared with those in propensity-score-matched controls without COVID-19 and in individuals with non-COVID respiratory illnesses (including both non-communicable respiratory conditions and non-COVID respiratory tract infections). We found that COVID-19 survivors had a higher likelihood of developing NOD compared to uninfected controls. This increased risk was primarily driven by VaD rather than AD; however, the risk did not surpass that observed among individuals with non-COVID respiratory illnesses. Notably, individuals with pre-existing mental health conditions were particularly vulnerable, exhibiting significantly higher risks of VaD following COVID-19 infection.

Nature
Full-body scans of 100,000 people could change way diseases are detected and treated - https://www.theguardian.com/science/2025/jul/15/full-body-scans-uk-biobank-project-diseases-detected-and-treated amazing stuff: “As we get older, we become more and more marbled,” she said. “We’re becoming wagyu beef.” #biobank
Full-body scans of 100,000 people could change way diseases are detected and treated

UK Biobank project to share 1bn images of organs, blood vessels and bones to help study ageing and ill health

The Guardian
Für schnellere medizinische Innovation & bessere Therapien: Der German Biobank Node wird Teil des Netzwerks Universitätsmedizin. Das verbessert den Datenaustausch, ermöglicht somit bessere klinische und epidemiologische Studien und ist der nächste Schritt auf dem Weg zur Nationalen #Biobank! #Präzisionsmedizin #Biobanking #Prävention #GBN #NUM

[5/5] Im Fokus des Beitrags des Instituts für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie (ILP) der #CharitéBerlin steht die technische Umsetzung der Befüllung der Probenröhrchen und die Aufbereitung der Blutbestandteile. Ziel des Projekts Multipen ist es, die Probenqualität zu verbessern.

👉 https://ilp.charite.de/metas/meldung/artikel/detail/ein_neuartiges_blutentnahme_und_lagerungssystem

#MedMastodon #Medizin #Forschung #Biobank #EFRE

Meldung-Detail: Charité – Universitätsmedizin Berlin

Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie - Charité – Universitätsmedizin Berlin

[4/5] Im Verbundprojekt „Multipen“ wird ein neuartiges Blutentnahme- und -lagerungssystem für Biobanken und klinische Studien entwickelt. Das Labor für Biofluidmechanik (LfB) des Deutschen Herzzentrums der #CharitéBerlin setzt dabei Wissen und Methoden der Strömungsmechanik ein, um einzelne Funktionselemente zu konzipieren und umzusetzen.

#MedMastodon #Medizin #Forschung #Biobank #EFRE

#23andMe Sale Shows Your #Genetic Data Is Worth $17

#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #genetics

https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/

23andMe Sale Shows Your Genetic Data Is Worth $17

23andMe sold the genetic data of 15 million people for $256 million to a pharmaceutical company called Regeneron.

404 Media
SciTech Chronicles. . . . . . . . .Mar 18th, 2025

  Hope clouds observation. Vol II No 70 497 links Curated Tornadoes are shifting east of Tornado Alley. https://www.livescience.com/planet-e...